Liang Huang

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

Huabin Hu, Liang Kang, Jianwei Zhang et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 278 citations

Neoadjuvant Pd-1 Blockade, Medicine, Immunology +7

Astragaloside IV alleviates mouse slow transit constipation by modulating gut microbiota profile and promoting butyric acid generation

Qiulan He, Changpeng Han, Liang Huang et al. · Journal of Cellular and Molecular Medicine · 2020 · 81 citations · Full text

A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer

Xiong Li, Huashan Liu, Chi Zhou et al. · Molecular Cancer · 2023 · 74 citations · Full text

Risk factors and surgical outcomes for spontaneous rupture of BCLC stages A and B hepatocellular carcinoma: a case-control study.

Jing Li, Liang Huang, Caifeng Liu et al. · PubMed · 2014 · 73 citations · Full text

Ginsenoside (Rg-1) promoted the wound closure of diabetic foot ulcer through iNOS elevation via miR-23a/IRF-1 axis

Hua‐An Cai, Liang Huang, Lijun Zheng et al. · Life Sciences · 2019 · 63 citations

Inflammation, Anti-inflammatory, Mir-23a/irf-1 Axis +9